Jensen, Sanne Brun <br/><br/>
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  09 2019 
 - 771-787 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.30647  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Aminoisobutyric Acids<br/>Anilides--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Carbamates--therapeutic use<br/>Cyclopropanes<br/>Denmark<br/>Drug Resistance, Viral--genetics<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--diagnosis<br/>Humans<br/>Lactams, Macrocyclic<br/>Leucine--analogs & derivatives<br/>Male<br/>Prognosis<br/>Proline--analogs & derivatives<br/>Protease Inhibitors--pharmacology<br/>Pyrrolidines<br/>Quinoxalines--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Uracil--analogs & derivatives<br/>Valine